Literature DB >> 11070005

Murine cytomegalovirus containing a mutation at open reading frame M37 is severely attenuated in growth and virulence in vivo.

M Lee1, J Xiao, E Haghjoo, X Zhan, G Abenes, T Tuong, W Dunn, F Liu.   

Abstract

A pool of murine cytomegalovirus (MCMV) mutants was generated by using a Tn3-based transposon mutagenesis procedure. One of the mutants, RvM37, which contained the transposon sequence at open reading frame M37, was characterized both in tissue culture and in immunocompetent BALB/c and immunodeficient SCID mice. Our results provide the first direct evidence to suggest that M37 is not essential for viral replication in vitro in NIH 3T3 cells. Compared to the wild-type strain and a rescued virus that restored the M37 region, the viral mutant was severely attenuated in growth in both BALB/c and SCID mice after intraperitoneal infection. Specifically, titers of the Smith strain and rescued virus in the salivary glands, lungs, spleens, livers, and kidneys of the SCID mice at 21 days postinfection were about 5 x 10(5), 2 x 10(5), 5 x 10(4), 5 x 10(3), and 1 x 10(4) PFU/ml of organ homogenate, respectively; in contrast, titers of RvM37 in these organs were less than 10(2) PFU/ml of organ homogenate. Moreover, the virulence of the mutant virus appeared to be significantly attenuated because none of the SCID mice infected with RvM37 had died by 120 days postinfection, while all animals infected with the wild-type and rescued viruses had died by 26 days postinfection. Our results suggest that M37 probably encodes a virulence factor and is required for MCMV virulence in SCID mice and for optimal viral growth in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070005      PMCID: PMC113190          DOI: 10.1128/jvi.74.23.11099-11107.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 2.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 3.  The genomes of the human herpesviruses: contents, relationships, and evolution.

Authors:  D J McGeoch
Journal:  Annu Rev Microbiol       Date:  1989       Impact factor: 15.500

4.  The murine cytomegalovirus M25 open reading frame encodes a component of the tegument.

Authors:  C A Wu; M E Carlson; S C Henry; J D Shanley
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

5.  Regeneration of herpesviruses from molecularly cloned subgenomic fragments.

Authors:  M van Zijl; W Quint; J Briaire; T de Rover; A Gielkens; A Berns
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  The efficacy of biological response modifiers against murine cytomegalovirus infection in normal and immunodeficient mice.

Authors:  M Okada; Y Minamishima
Journal:  Microbiol Immunol       Date:  1987       Impact factor: 1.955

7.  Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis.

Authors:  P C Weber; M Levine; J C Glorioso
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

8.  Effect of Nu/Nu gene on genetically determined resistance to murine cytomegalovirus.

Authors:  J E Grundy; C J Melief
Journal:  J Gen Virol       Date:  1982-07       Impact factor: 3.891

9.  Application of the mini-Mu-phage for target-sequence-specific insertional mutagenesis of the herpes simplex virus genome.

Authors:  F J Jenkins; M J Casadaban; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

Review 10.  Latent infection and the elusive cytomegalovirus.

Authors:  M C Jordan
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr
View more
  9 in total

1.  Characterization of the murine cytomegalovirus m136 gene.

Authors:  Robert J Visalli; Denise M Nicolosi; Karen Irven; Tamseel Khan; Melissa A Visalli
Journal:  Virus Genes       Date:  2006-12-02       Impact factor: 2.332

2.  In vitro and in vivo characterization of a murine cytomegalovirus with a mutation at open reading frame m166.

Authors:  Jiaming Zhu; Jennifer Chen; Rong Hai; Tuong Tong; Jianqiao Xiao; Xiaoyan Zhan; Sangwei Lu; Fenyong Liu
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  A focused salivary gland infection with attenuated MCMV: an animal model with prevention of pathology associated with systemic MCMV infection.

Authors:  Mark J Pilgrim; Laura Kasman; Jasvir Grewal; Mary E Bruorton; Phil Werner; Lucille London; Steven D London
Journal:  Exp Mol Pathol       Date:  2007-01-12       Impact factor: 3.362

4.  Convergence of RNA cis elements and cellular polyadenylation factors in the regulation of human cytomegalovirus UL37 exon 1 unspliced RNA production.

Authors:  Yan Su; Richard Adair; Candice N Davis; Nancy L DiFronzo; Anamaris M Colberg-Poley
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  Murine cytomegalovirus m38.5 protein inhibits Bax-mediated cell death.

Authors:  Igor Jurak; Uwe Schumacher; Hrvoje Simic; Sebastian Voigt; Wolfram Brune
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

6.  Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes.

Authors:  Paul Lacaze; Thorsten Forster; Alan Ross; Lorraine E Kerr; Eliane Salvo-Chirnside; Vanda Juranic Lisnic; Guillermo H López-Campos; José J García-Ramírez; Martin Messerle; Joanne Trgovcich; Ana Angulo; Peter Ghazal
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

7.  In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome.

Authors:  Husam Taher; Eisa Mahyari; Craig Kreklywich; Luke S Uebelhoer; Matthew R McArdle; Matilda J Moström; Amruta Bhusari; Michael Nekorchuk; Xiaofei E; Travis Whitmer; Elizabeth A Scheef; Lesli M Sprehe; Dawn L Roberts; Colette M Hughes; Kerianne A Jackson; Andrea N Selseth; Abigail B Ventura; Hillary C Cleveland-Rubeor; Yujuan Yue; Kimberli A Schmidt; Jason Shao; Paul T Edlefsen; Jeremy Smedley; Timothy F Kowalik; Richard J Stanton; Michael K Axthelm; Jacob D Estes; Scott G Hansen; Amitinder Kaur; Peter A Barry; Benjamin N Bimber; Louis J Picker; Daniel N Streblow; Klaus Früh; Daniel Malouli
Journal:  PLoS Pathog       Date:  2020-11-24       Impact factor: 7.464

8.  Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.

Authors:  Wei Li; Yujun Liu; Yuanyuan Wang; Ruilin Li; Phong Trang; Wei Tang; Zhu Yang; Yu Wang; Xu Sun; Xiwen Xing; Sangwei Lu; Fenyong Liu
Journal:  Theranostics       Date:  2018-11-09       Impact factor: 11.556

9.  Inhibition of Murine Cytomegalovirus Infection in Animals by RNase P-Associated External Guide Sequences.

Authors:  Wei Li; Jingxue Sheng; Mengqiong Xu; Gia-Phong Vu; Zhu Yang; Yujun Liu; Xu Sun; Phong Trang; Sangwei Lu; Fenyong Liu
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.